Company Monitoring Page for MannKind

latest headlines for company on cafepharma

MannKind Investors: Don't Screw Up The Afrezza Launch
Seeking Alpha
Tue, 02/10/15 - 06:42 pm
Tags:
MannKind, investors, Afrezza, diabetes, drug launches
On MannKind, Diabetics Have One Up On Wall Street
Forbes
Sun, 02/8/15 - 09:58 am
Tags:
MannKind, Afrezza, Sanofi, diabetes
What MannKind Investors Can Learn From The Sanofi Conference Call
Seeking Alpha
Thu, 02/5/15 - 05:11 pm
Tags:
MannKind, Sanofi, Afrezza, diabetes, inhaled insulin
Can Sanofi's kinder, gentler, inhalable Afrezza win reluctant patients over to insulin?
Fierce Pharma Marketing
Wed, 02/4/15 - 10:26 am
Tags:
Sanofi, Afrezza, inhaled insulin, insulin, diabetes, MannKind
Sanofi SA (ADR) (SNY) Launches Inhaled Insulin Afrezza
Bidness Etc.
Tue, 02/3/15 - 08:59 am
Tags:
Sanofi, inhaled insulin, Afrezza, diabetes, insulin, drug launches, MannKind
Afrezza Breathes Life Into MannKind
Forbes
Tue, 01/27/15 - 04:36 pm
Tags:
Afrezza, MannKind, diabetes, inhaled insulin
The Real News About Afrezza From The JPMorgan Conference
Seeking Alpha
Tue, 01/20/15 - 01:59 pm
Tags:
Afrezza, MannKind, diabetes, inhaled insulin, JPMHC 2015
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
MannKind: Small step for delivery tech R&D after Afrezza's giant leap
In-Pharma Technologist
Mon, 01/19/15 - 04:06 pm
Tags:
R&D, MannKind, Afrezza, drug delivery
MannKind COO Hakan Edstrom appointed CEO after founder steps down
Fierce Biotech
Sat, 01/17/15 - 03:59 pm
Tags:
MannKind, Hakan Edstrom, Pharma CEOs, Alfred Mann
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger
Yahoo/Benzinga
Mon, 01/12/15 - 07:30 pm
Tags:
MannKind, R&D, Afrezza, diabetes, M&A, Sanofi
MannKind Gets Little Love From Sanofi at 'JPM15' Presentation
TheStreet.com
Mon, 01/12/15 - 03:34 pm
Tags:
MannKind, diabetes, Sanofi, Afrezza, inhaled insulin, JPMHC 2015
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 2
TheStreet.com
Fri, 01/9/15 - 09:18 am
Tags:
biotech, JPMHC 2015, Juno Therapeutics, AbbVie, MannKind, EXACT Sciences, NewLink Genetics
History Suggests MannKind Corporation's Afrezza Could Already Be Doomed
Motley Fool
Fri, 01/9/15 - 08:30 am
Tags:
MannKind, Afrezza, inhaled insulin, insulin, diabetes, drug pricing
Fifteen Fabulously Intelligent Biotech Stock Predictions for 2015
TheStreet.com
Tue, 01/6/15 - 08:52 am
Tags:
Sanofi, MannKind, Gilead Sciences, Santhera, Puma Biotechnology, Bluebird Bio, Celgene, Pfizer, Biogen Idec
Can MannKind Corporation Stock Soar in 2015?
Motley Fool
Wed, 12/31/14 - 08:54 am
Tags:
MannKind, Afrezza, insulin, inhaled insulin
3 Companies Growing Faster Than MannKind Corporation
Motley Fool
Wed, 12/17/14 - 08:13 am
Tags:
MannKind, Alexion, Akorn, Acorda Therapeutics
Is MannKind Corporation in Bed With Crooks? And Should Investors Care?
Motley Fool
Fri, 12/12/14 - 08:45 am
Tags:
MannKind, Sanofi, Afrezza
Mannkind Reality Check Redux: 82.4 Million Reasons To Leave Your Lover!
Seeking Alpha
Tue, 12/9/14 - 07:57 am
Tags:
MannKind, Sanofi, diabetes, Afrezza
Losing Confidence In MannKind
Seeking Alpha
Fri, 12/5/14 - 10:57 am
Tags:
MannKind, Afrezza, diabetes

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.